Universal Beteiligungs und Servicegesellschaft mbH Sells 9,703 Shares of Agilent Technologies, Inc. $A

Universal Beteiligungs und Servicegesellschaft mbH trimmed its position in Agilent Technologies, Inc. (NYSE:AFree Report) by 1.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 631,350 shares of the medical research company’s stock after selling 9,703 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.22% of Agilent Technologies worth $81,034,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Chicago Partners Investment Group LLC raised its stake in shares of Agilent Technologies by 18.3% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 4,298 shares of the medical research company’s stock valued at $552,000 after purchasing an additional 666 shares during the period. Sage Mountain Advisors LLC increased its position in shares of Agilent Technologies by 21.9% in the third quarter. Sage Mountain Advisors LLC now owns 4,206 shares of the medical research company’s stock valued at $540,000 after acquiring an additional 755 shares during the last quarter. Jackson Thornton Wealth Management LLC acquired a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $291,000. Root Financial Partners LLC bought a new stake in Agilent Technologies during the third quarter worth $107,000. Finally, Pacific Heights Asset Management LLC grew its holdings in Agilent Technologies by 17.6% during the third quarter. Pacific Heights Asset Management LLC now owns 120,000 shares of the medical research company’s stock worth $15,402,000 after purchasing an additional 18,000 shares during the period.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 12,490 shares of the firm’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the transaction, the chief executive officer directly owned 33,448 shares of the company’s stock, valued at approximately $5,017,200. This trade represents a 27.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Rodney Gonsalves sold 3,000 shares of Agilent Technologies stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the transaction, the vice president owned 31,846 shares in the company, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 16,401 shares of company stock valued at $2,468,962.

Agilent Technologies Trading Down 2.8%

A opened at $135.74 on Wednesday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52. The company’s 50-day moving average is $144.00 and its 200 day moving average is $133.77. The firm has a market capitalization of $38.48 billion, a PE ratio of 29.70, a P/E/G ratio of 4.05 and a beta of 1.29.

Agilent Technologies (NYSE:AGet Free Report) last released its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.58 by $0.01. The business had revenue of $1.86 billion for the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The firm’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same period in the previous year, the company earned $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, research analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be given a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, January 6th. Agilent Technologies’s dividend payout ratio (DPR) is 22.32%.

Wall Street Analysts Forecast Growth

A has been the topic of several research analyst reports. The Goldman Sachs Group assumed coverage on shares of Agilent Technologies in a research report on Tuesday, December 9th. They issued a “buy” rating and a $170.00 price objective on the stock. Bank of America lifted their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 25th. Barclays upgraded Agilent Technologies from an “equal weight” rating to an “overweight” rating and set a $165.00 price target on the stock in a research report on Monday, December 15th. Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. Finally, Robert W. Baird increased their target price on shares of Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a report on Tuesday, November 25th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $164.50.

View Our Latest Report on A

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Featured Stories

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.